Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Evolve Telemed vs Metabolyz

Evolve Telemed
Graded #378

Lower grade

vs+1.5
Metabolyz
Graded #339

Higher grade

The verdict

Metabolyz takes it — 59.6/100 to 58.1/100, but only just.

Metabolyz grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Metabolyz is a nationwide GLP-1 telehealth platform offering three compounded programs — standard semaglutide, dual-agonist tirzepatide, and a microdose protocol for patients near goal weight or intolerant… Evolve Telemed is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEvolve Telemed +13
53
40
Clinical oversightEvolve Telemed +2
83
81
Labs & monitoringMetabolyz +11
52
63
FulfillmentMetabolyz +24
62
86
Contract termsEven
55
55
Evolve Telemed · left barMetabolyz · right bar

The numbers

MetricEvolve TelemedMetabolyz
WeighScore58.1/10059.6/100
GradeCC
Scorecard rank#378#339
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Evolve Telemed

Graded #378 · C

Strengths

  • Established hormone- and peptide-optimization brand with board-certified specialists and a physician-plus-care-specialist support model
  • Compounded GLP-1 (semaglutide) weight care offered alongside TRT, menopause/BHRT, thyroid and sexual-wellness programs in one practice
  • Coordinated couples care plans plus dedicated men's and women's tracks
  • Free consultation to start, with published press, blog and FAQ resources

Where it loses points

  • No GLP-1 pricing published — cost is only revealed after a consultation, so you can't compare value upfront
  • Doesn't list the states it serves or name its compounding pharmacies
  • Weight loss is one of many verticals, not a dedicated GLP-1-first program
  • Tirzepatide availability isn't confirmed on the site; only compounded semaglutide is referenced
  • Not shown on our price-ranked /best lists because no pricing is disclosed
Metabolyz

Graded #339 · C

Strengths

  • Three GLP-1 programs: standard semaglutide, dual-agonist tirzepatide, and a microdose protocol for near-goal or dose-sensitive patients
  • Nutrition, movement, and lifestyle coaching included in all programs at no extra charge
  • Medication compounded in licensed 503A/503B US pharmacies with temperature-controlled, unmarked direct-to-door delivery
  • Licensed provider supervision with direct messaging access and structured check-ins throughout
  • Telehealth across all 50 states; BMI 27+ eligibility (25+ with weight-related condition)

Where it loses points

  • Pricing is fully gated — not disclosed until after consultation, preventing upfront cost comparison
  • Compounded GLP-1 only — no brand-name options (Wegovy, Zepbound) available
  • No LegitScript certification or named medical leadership found on public-facing pages
  • Labs not mentioned as included — unclear whether baseline or follow-up bloodwork is offered
  • Newer brand with no external reviews, published outcomes data, or notable accreditations

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard